LoginSignup
KRK

Krka

Stock
Stock
ISIN: SI0031102120
Ticker: KRKG
SI0031102120
KRKG

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Krka has so far distributed $9.698 in 2025. 

$5.771

CHART BY

Frequently asked questions

What is Krka's market capitalization?

The market capitalization of Krka is $7.14B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Krka's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Krka is 16.08. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Krka?

Krka's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $14.53. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Krka's stock?

Currently, 5 analysts cover Krka's stock, with a consensus target price of $205.30. Analyst ratings provide insights into the stock's expected performance.

What is Krka's revenue over the trailing twelve months?

Over the trailing twelve months, Krka reported a revenue of $2.31B.

What is the EBITDA for Krka?

Krka's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $621.21M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Krka?

Krka has a free cash flow of $378.19M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Krka have, and what sector and industry does it belong to?

Krka employs approximately 12,810 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.

What is the free float of Krka's shares?

The free float of Krka is 20.30M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$7.14B
EPS (TTM) 
$14.53
Free Float 
20.30M
P/E ratio (TTM) 
16.08
Revenue (TTM) 
$2.31B
EBITDA (TTM) 
$621.21M
Free Cashflow (TTM) 
$378.19M

Pricing

1D span
$233.23$235.84
52W span
$141.98$235.36

Analyst Ratings

The price target is $205.30 and the stock is covered by 5 analysts.

Buy

3

Hold

2

Sell

0

Information

KRKA dd is a generic pharmaceutical company, which engages in the development, production, marketing, and sale of human and animal health products. It operates through the following geographical segments: European Union, South-Eastern Europe, Eastern Europe, and Other. The European Union segment includes all countries of the European Union. The South-Eastern Europe segment consists of Serbia, Bosnia and Herzegovina, Macedonia, Montenegro, Kosovo, and Albania. The Eastern Europe segment comprises of the Russian Federation and other former Soviet Union countries, excluding the Baltic countries. The company was founded by Boris Andrijanic in 1954 and is headquartered in Novo Mesto, Slovenia.

Employees
12,810
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
SI0031102120
Primary Ticker
KRKG

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin